The new business, Haleon, is expected to be valued in the region of £45billion, including debt. The company, with £10billion worth of sales, owns brands such as Sensodyne and Panadol. The company, with £10billion worth of sales, owns brands such as Sensodyne and Panadol. The break-up is designed to allow GSK, one of Britain's biggest and oldest public companies, to unlock investment in its vaccines and other ventures to boost research.